Correlation Between Dyadic International and Transcode Therapeutics
Can any of the company-specific risk be diversified away by investing in both Dyadic International and Transcode Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dyadic International and Transcode Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dyadic International and Transcode Therapeutics, you can compare the effects of market volatilities on Dyadic International and Transcode Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dyadic International with a short position of Transcode Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dyadic International and Transcode Therapeutics.
Diversification Opportunities for Dyadic International and Transcode Therapeutics
-0.52 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Dyadic and Transcode is -0.52. Overlapping area represents the amount of risk that can be diversified away by holding Dyadic International and Transcode Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Transcode Therapeutics and Dyadic International is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dyadic International are associated (or correlated) with Transcode Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Transcode Therapeutics has no effect on the direction of Dyadic International i.e., Dyadic International and Transcode Therapeutics go up and down completely randomly.
Pair Corralation between Dyadic International and Transcode Therapeutics
Given the investment horizon of 90 days Dyadic International is expected to under-perform the Transcode Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Dyadic International is 2.05 times less risky than Transcode Therapeutics. The stock trades about -0.06 of its potential returns per unit of risk. The Transcode Therapeutics is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest 895.00 in Transcode Therapeutics on November 30, 2025 and sell it today you would earn a total of 66.00 from holding Transcode Therapeutics or generate 7.37% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 98.36% |
| Values | Daily Returns |
Dyadic International vs. Transcode Therapeutics
Performance |
| Timeline |
| Dyadic International |
| Transcode Therapeutics |
Dyadic International and Transcode Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Dyadic International and Transcode Therapeutics
The main advantage of trading using opposite Dyadic International and Transcode Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dyadic International position performs unexpectedly, Transcode Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Transcode Therapeutics will offset losses from the drop in Transcode Therapeutics' long position.| Dyadic International vs. RenovoRx | Dyadic International vs. Alterity Therapeutics | Dyadic International vs. Elutia Inc | Dyadic International vs. Annovis Bio |
| Transcode Therapeutics vs. Aprea Therapeutics | Transcode Therapeutics vs. Adial Pharmaceuticals | Transcode Therapeutics vs. Kiora Pharmaceuticals | Transcode Therapeutics vs. Cardio Diagnostics Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |